Acta Pharmaceutica Sinica B · 2024 · 18 citations · 27 references
MedicineOncologyPharmacologyCancer PharmacologyDrug DeliveryMolecular OncologyCancer Cell SignalingCancer NanomedicineCancer-associated FibroblastsNanomedicinePancreatic CancerTargeted Cancer TherapyAnticancer Drug LoadingCa2+ SignalingCancer-associated Fibroblast TargetingExosome-based TherapyExosomesExosomes In CancerMesenchymal TransitionTumor-derived Exosomes
The application of extracellular vehicles (EVs), particularly exosomes, is rapidly expanding in the field of medicine, thanks to their remarkable properties as natural carriers of biological cargo. This study investigates utilization of exosomes derived from stromal cells of tumor adjacent normal tissues (NAF-EXs) for personalized medicine, which can be derived at the time of diagnosis by endoscopic ultrasound. Herein, we showcase that EXs derived from NAFs demonstrate differential bio-physical characteristics, efficient cellular internalization, drug loading efficiency, pancreatic tumor targeting and delivery of payloads. NAF-derived EXs (NAF-EXs) were used for loading ormeloxifene (ORM), a potent anti-cancer and desmoplasia inhibitor as a model drug. We found that ORM maintains normal fibroblast cell phenotype and renders them incompatible to be triggered for a CAF-like phenotype, which may be due to regulation of Ca2+ influx in fibroblast cells. NAF-EXs-ORM effectively blocked oncogenic signaling pathways involved in desmoplasia and epithelial mesenchymal transition (EMT) and repressed tumor growth in xenograft mouse model. In conclusion, our data suggests preferential tropism of NAF-EXs for PDAC tumors, thus imply feasibility of developing a novel personalized medicine for PDAC patients using autologous NAF-EXs for improved therapeutic outcome. Additionally, it provides the opportunity of utilizing this biological scaffold for effective therapeutics in combination with standard therapeutic regimen.
27
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse, Jaeil Ahn, Rehan Akbani et al. · Cell · 2015 · 3.2K citations · Full text
Yanhua Tian, Suping Li, Jian Song et al. · Biomaterials · 2013 · 1.8K citations
Pharmacy, Oncology, Pharmaceutics +16
Shengming Dai, Dong Wei, Zhen Wu et al. · Molecular Therapy · 2008 · 789 citations · Full text
Medicine, Cell Biology, Oncology +11